What was the Chemistry Nobel Prize given for? | Explained

The 2026 Nobel Prize in Chemistry has been awarded to Henri Kagan and Kenso Soai for their groundbreaking research on amplifying a molecule's "handedness." This discovery allows for the production of pharmaceutical products with a very high degree of purity. The concept behind their work lies in the phenomenon of "chirality," which refers to the mirror-image property of certain chemical molecules, such as those found in DNA and other organic molecules.

Living organisms overwhelmingly exhibit a form of homochirality, where all amino acids have the "left" (L) form and every sugar in DNA has the "right" (D) form. This consistent handedness is unlike ordinary laboratory reactions that typically produce a 50:50 mix of both forms, also known as a "racemate."

The team's research not only explains how life on Earth could have evolved from simple molecules but also sheds light on the crucial role chiral molecules play in drug development. The effectiveness of many drugs relies on their ability to attach to the surface of enzymes or receptors, similar to a password fitting a lock. However, the same password written in the wrong order can be harmless or even harmful, as seen with the drug thalidomide, which caused birth defects in the early 1960s.

Kagan and Soai's discovery has significant implications for the pharmaceutical industry, as it enables scientists to create and administer products composed of the desired enantiomer, while minimizing the presence of the less effective form. This leads to more efficient use of medications, potentially reducing side effects and improving patient outcomes.